Net profit of Ajanta Pharma rose 18.09% to Rs 245.77 crore in the quarter ended June 2024 as against Rs 208.12 crore during the previous quarter ended June 2023. Sales rose 12.13% to Rs 1144.92 crore in the quarter ended June 2024 as against Rs 1021.04 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 1144.92 | 1021.04 | 12 |
| OPM % | 28.85 | 26.57 | - |
| PBDT | 356.09 | 302.22 | 18 |
| PBT | 322.12 | 269.04 | 20 |
| NP | 245.77 | 208.12 | 18 |